During the last session, TNF Pharmaceuticals Inc (NASDAQ:TNFA)’s traded shares were 2.7 million, with the beta value of the company hitting 2.15. At the end of the trading day, the stock’s price was $0.20, reflecting an intraday gain of 2.08% or $0.01. The 52-week high for the TNFA share is $2.91, that puts it down -1355.0 from that peak though still a striking 20.0% gain since the share price plummeted to a 52-week low of $0.16. The company’s market capitalization is $1.99M, and the average trade volume was 1.50 million shares over the past three months.

TNF Pharmaceuticals Inc (NASDAQ:TNFA) trade information

TNF Pharmaceuticals Inc (TNFA) registered a 2.08% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 2.08% in intraday trading to $0.20, hitting a weekly high. The stock’s 5-day price performance is -2.24%, and it has moved by -25.28% in 30 days. Based on these gigs, the overall price performance for the year is -93.58%.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 50.65%.

TNFA Dividends

TNF Pharmaceuticals Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Also, the Mutual Funds coming in first place with the largest holdings of TNF Pharmaceuticals Inc (TNFA) shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . Data provided on Mar 31, 2025 indicates that Fidelity Concord Street Trust-Fidelity Extended Market Index Fund owns about 21.64 shares. This amounts to just over 0.21 percent of the company’s overall shares, with a $4254.0 market value. The same data shows that the other fund manager holds slightly less at 13.69, or about 0.14% of the stock, which is worth about $2691.0.